MANUEL PENALVER, MD
Gynecologic Oncology Physician in CORAL GABLES, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MANUEL PENALVER, MD reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 665 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 665
- Part D claims, 2023
- 90%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MANUEL PENALVER, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MANUEL PENALVER, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MANUEL PENALVER, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Gynecologic Oncology Physician compares to other specialties among Florida providers
Gynecologic Oncology Physician share within Florida
Gynecologic Oncology Physician is one of the more visible NUCC categories in Florida
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MANUEL PENALVER, MD's 2023 MIPS final score plotted against the Gynecologic Oncology Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Gynecologic Oncology Physician) — 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Gynecologic Oncology Physician US NPIs
100/100 MIPS final score — 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Gynecologic Oncology Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MANUEL PENALVER, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 5000 UNIVERSITY DR, CORAL GABLES, FL, 33146, with a listed phone of (305) 663-7001. NPI 1821095829 was issued on 07/05/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PENALVER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 665 prescription claims written by this provider, covering 350 Medicare beneficiaries and totaling roughly $51K in drug spend, split 10% brand-name and 90% generic by claim count, with an opioid prescribing rate of 21.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year, compared with the national average of 83.1.
Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1821095829 |
|---|---|
| Specialty | Gynecologic Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/05/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MANUEL PENALVER, MD's current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where MANUEL PENALVER, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MANUEL PENALVER, MD. Source: openpaymentsdata.cms.gov.
Total received
$853
Largest payer
INTUITIVE SURGICAL, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to MANUEL PENALVER, MD. To verify MANUEL PENALVER, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
10% brand-name claims vs 90% generic, on 665 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,145
- Total Day Supply
- 27,484
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $23K
- Generic Drug Cost
- $28K
- Opioid Claims
- 143 (21.5% rate)
- Antibiotic Claims
- 42
Patient Demographics
- Average Patient Age
- 72.2 years
- Avg HCC Risk Score
- 1.63
- Gender Split
- 100% female / 0% male
- Age Distribution
- <65: 28, 65-74: 192, 75-84: 104, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MANUEL PENALVER, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Estradiol
Estradiol
192 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
143 claims
- Alclometasone Dipr…
Alclometasone Dipropionate
87 claims
- Ciprofloxacin Hcl 31
Ciprofloxacin Hcl
31 claims
- Oxybutynin Chlorid… 24
Oxybutynin Chloride Er
24 claims
- Metronidazole 17
Metronidazole
17 claims
- Clotrimazole-Betam… 14
Clotrimazole-Betamethasone
14 claims
- Mometasone Furoate 12
Mometasone Furoate
12 claims
| Drug | Claims |
|---|---|
| Estradiol | 192 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 143 |
| Alclometasone Dipropionate | 87 |
| Ciprofloxacin Hcl | 31 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 24 |
| Metronidazole | 17 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 14 |
| Mometasone Furoate | 12 |
| Premarin "Estrogens | N/A |
| Progesterone "Progesterone | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gynecologic Oncology Physician Overview
How MANUEL PENALVER, MD fits within the Gynecologic Oncology Physician landscape nationally.
MANUEL PENALVER, MD's 665 claims are above the specialty average of 188.
Nearby Gynecologic Oncology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as PENALVER.
Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is MANUEL PENALVER, MD's specialty? ▼
How much does MANUEL PENALVER, MD prescribe under Medicare Part D? ▼
What is MANUEL PENALVER, MD's Medicare quality score? ▼
Where is MANUEL PENALVER, MD located? ▼
What is MANUEL PENALVER, MD's NPI number? ▼
Does MANUEL PENALVER, MD prescribe more brand-name or generic drugs? ▼
Does MANUEL PENALVER, MD prescribe opioids? ▼
How many Gynecologic Oncology Physician providers are there in the US? ▼
What drugs does MANUEL PENALVER, MD prescribe most often? ▼
Does MANUEL PENALVER, MD accept Medicare? ▼
How can I verify MANUEL PENALVER, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology